TOI Oncology Institute Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TOI

Price (delayed)

$5.28

Market cap

$527.91M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$50,304.82

Enterprise value

$602.49M

?
Relative Growth: Rel. Growth: 78
Relative Strength: Rel. Strength: 91
Relative Valuation: Rel. Valuation: 30
Relative Profitability: Rel. Profitability: 19
Highlights
The gross profit is up by 39% year-on-year and by 8% since the previous quarter
TOI's revenue is up by 35% year-on-year and by 9% since the previous quarter
The quick ratio has contracted by 25% YoY and by 14% from the previous quarter
TOI's equity is down by 3.6% since the previous quarter
Sector: Healthcare
Industry: Medical Care Facilities

Key stats

What are the main financial stats of TOI

TOI stock price

How has the Oncology Institute stock price performed over time
Intraday
-4.17%
1 week
3.13%
1 month
15.03%
1 year
116.39%
YTD
48.31%
QTD
-2.76%

Financial performance

How have Oncology Institute's revenue and profit performed over time
Revenue
$545.76M
Gross profit
$82.5M
Operating income
-$32.69M
Net income
-$46.58M
Gross margin
15.1%
Net margin
-8.5%
Oncology Institute's operating margin has soared by 53% YoY and by 17% from the previous quarter
The company's net margin rose by 47% YoY and by 30% QoQ
The gross profit is up by 39% year-on-year and by 8% since the previous quarter
The operating income rose by 37% year-on-year and by 9% since the previous quarter

Price vs fundamentals

How does TOI's price correlate with its fundamentals

Growth

What is Oncology Institute's growth rate over time

Valuation

What is Oncology Institute stock price valuation
TOI P/E details
P/E
N/A
P/B
N/A
P/S
0.98
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.1
The EPS has grown by 5% YoY
TOI's equity is down by 3.6% since the previous quarter
The P/S is 63% more than the last 4 quarters average of 0.6 and 9% more than the 5-year quarterly average of 0.9
TOI's revenue is up by 35% year-on-year and by 9% since the previous quarter

Efficiency

How efficient is Oncology Institute business performance
The ROS has grown by 45% YoY and by 27% from the previous quarter
The ROA is up by 24% since the previous quarter and by 23% year-on-year
The company's return on invested capital rose by 21% QoQ and by 13% YoY

Dividends

What is TOI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TOI.

Financial health

How did Oncology Institute financials performed over time
The total assets is 9% less than the total liabilities
The quick ratio has contracted by 25% YoY and by 14% from the previous quarter
The current ratio has contracted by 18% YoY and by 8% from the previous quarter
The debt to equity has plunged by 132% YoY but it has grown by 2.4% from the previous quarter
TOI's equity is down by 3.6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.